Golden State Medical Supply is recalling several lots of Ranitidine capsules, a medication used to treat heartburn and stomach ulcers, due to the detection of an impurity called N-nitrosodimethylamine (NDMA). The recall affects Ranitidine 150 mg in 500-count bottles and Ranitidine 300 mg in 100-count bottles. NDMA is a substance that is classified as a probable human carcinogen, meaning it could increase the risk of cancer with long-term exposure. Consumers should contact their doctor or pharmacist to discuss alternative treatments.
The product was found to contain an impurity called NDMA, which is a known environmental contaminant and a probable human carcinogen. While NDMA is common at low levels in water and foods, exposure to higher levels over time may increase the risk of developing cancer.
Drug recall remedy instructions
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.